Clinical implications of axillary sentinel lymph node 'micrometastases' in breast cancer

European Journal of Surgical Oncology

Volumn 32, Issue 4, 2006, Pages 400-404

  Krauth, J S ^a   Charitansky, H ^a   Isaac, S ^a   Bobin, J Y ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Breast cancer; Micrometastases; Sentinel lymph node

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CONTROL; CANCER INVASION; CONTROLLED STUDY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 33646172412     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.01.003     Document Type: Article

References (26)

1. National Institute of Health. NIH consensus conference on the treatment of early breast cancer. JAMA 265 (1991) 391-395
2. Carter C.L., Allen C., and Henson D.E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63 (1989) 181-187
3. NIH Consensus Development Conference. NIH-Consensus Statement 1992;8:1-9.
4. Fisher B., Wolmark N., Bauer M., Redmond C., and Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152 (1981) 765-772
5. Krag D.N., Weaver D.L., Alex J.C., and Fairbank J.T. Surgical resection and radiolocalization of the sentinel node in breast cancer using gamma probe. Surg Oncol 2 (1993) 335-337
6. Giuliano A.E., Kirgan D.M., Guenther J.M., and Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-401
7. Veronesi U., Paganelli G., Viale G., Luini A., Zurrida S., Galimberti V., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 10 (2003) 179-187
8. Miltenburg D.M., Miller C., and Brunicardi F.C. Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 84 (1999) 138-142
9. Fraile M., Rull M., Julian F.J., Fuste F., Barnadas A., Llatjos M., et al. Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol 11 (2000) 701-705
10. Giuliano A.E., Haigh P.I., Brennan M.B., Hansen N.M., Kelley M.C., Ye W., et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18 (2000) 2553-2559
11. Revision of the American Joint Committee on Cancer Staging System for Breast Cancer. J Clin Oncol 20 (2002) 3628-3636
12. Singletary S.E., and Greene F.L. Revision of the Breast Cancer Staging: the 6th edition of the TNM classification. Semin Surg Oncol 21 (2003) 53-59
13. European Working Group for Breast Screening Pathology (EWGBSP). Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39 (2003) 1654-1667
14. Cserni G., Gregori D., Merletti F., Sapino A., Mano M.P., Ponti A., et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 91 (2004) 1245-1252
15. Degnim A.C., Griffith K.A., Sabel M.S., Hayes D.F., Cimmino Vm., Diehl K.M., et al. Clinicopathologic features of metastasis in non sentinel lymph nodes of breast carcinoma patients. A metaanalysis. Cancer 98 (2003) 2307-2315
16. Huvos A.G., Hutter R., and Berg J.W. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 173 (1971) 44-46
17. Attiyeh F.F., Jensen M., Huvos A.G., and Fracchia A. Axillary micrometastases and macrometastases in carcinoma of the breast. Surg Gynecol Obstet 144 (1977) 839-842
18. Fisher E.R., Swamidoss S., Lee C.H., Rockette H., Redmond C., and Fisher B. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 42 (1978) 2025-2031
19. Fisher E.R., Palekar A., Rockette H., Redmond C., and Fischer B. Pathologics findinSLN from the NSABP-04. Significance of axillary nodal micro- and macrometastases. Cancer 42 (1978) 2032-2038
20. Langer I., Marti W.R., Guller U., Moch H., Harder F., Oertli D., et al. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN metastases. Prospective analysis of 150 patients after SLN biopsy. Ann Surg 241 (2005) 152-158
21. Dowlatshahi K., Ming F., Snider H.C., and Habib F.A. Lymph node micrometastases from breast carcinoma. Reviewing the dilemma. Cancer 80 (1997) 1188-1197
22. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 337 (1991) 1110-1114
23. Fischer B., Jeong J.H., Anderson S., Bryant J., Fisher E.R., and Wolmark N. Twenty-five-years follow-up of a randomized trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N Engl J Med 347 (2002) 567-575
24. Cancer research campaign (King's/Cambridge) trial for early breast cancer. A detailed update at the tenth year. Cancer Research Campaign Working Party. Lancet 1980;2:55-60.
25. Veronesi U., Salvadori B., Luini A., Banfi A., Zucali R., Del Vecchio M., et al. Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg 211 (1990) 250-259
26. Naik A.M., Fey J., Gemignani M., Heerdt A., Montgomery L., Petrek J., et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 240 (2004) 462-468